The psychobiologioal basis of posttraumatic stress disorder

Molecular Psychiatry

Volumn 1, Issue 4, 1996, Pages 278-297

  Grillon, C ^a   Southwick, S M ^b   Charney, D S ^b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

Anxiety; Human; Neurobiology; Posttraumatic stress disorder; Trauma

Indexed keywords

HUMAN; PATHOPHYSIOLOGY; POSTTRAUMATIC STRESS DISORDER; PSYCHOLOGICAL ASPECT; REVIEW;

HUMANS; STRESS DISORDERS, POST-TRAUMATIC;

EID: 0030229895     PISSN: 13594184     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (259)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4 edn, Washington, DC, 1994.
2. Kulka R, Schlenger W, Fairbank J, Hough R, Jordan B, Marmar C, Weiss D. Trauma and the Vietnam War Generation. Brunner/Mazel: New York, 1990.
3. Heizer JE, Robins LN, McEvoy L. Posttraumatic stress disorder in the general population: findings of the Epidemiologic Catchment Area Survey. N Engl J Med 1987; 317: 1630-1634.
4. Resnick HS, Kilpatrick DG, Dansky BS, Saunders BE, Best CL. Prevalence of civilian trauma and posttraumatic stress disorder in a representative national sample of women. J Cons Clin Psychol 1993; 61: 984-991.
5. Kardiner A. The Traumatic Neurosis of War. Paul Hoeber: New York, 1941.
6. Davis M, Falls WA, Campeau S, Kim M. Fear-potentiated startle: a neural and pharmacological analysis. Behav Brain Res 1993; 58: 175-198.
7. Lang PJ, Bradley MM, Cuthbert BN. Emotion, attention, and the startle reflex. Psychol Rev 1990; 97: 1-19.
8. Grinker RR, Spiegel JP. Men Under Stress. Blakiston: Philadelphia, 1945.
9. Kardiner A, Spiegel H. War, Stress and Neurotic Illness. Paul Hoeber: New York, 1941.
10. Selye H. Stress syndrome. A syndrome produced by diverse noxious agents. Nature 1937; 138: 32.
11. Gray JA. The hippocampus as an interface between cognition and emotion. In: Roitblat HL, Bevor TG, Terrace HS (eds). Animal Cognition. Erlbaum: Hillsdale, NJ, 1984.
12. Mason JW. Psychologic stress and endocrine function. In: Sachar EJ (ed). Topics in Psychoendocrinology. Grune & Stratton: New York, 1975.
13. Kosten T, Jacobs S, Mason J, Wahby V, Atkins S. Psychological correlates of growth hormone response to stress. Psychosom Med 1984; 46: 49-58.
14. Deutch AY, Young CD. A model of the stress-induced activation of prefrontal cortical dopamine systems: coping and the development of post-traumatic stress disorder. In: Friedman MJ, Charney DS, Deutch AY (eds). Neurobiological and Clinical Consequences of Stress: from Normal Adaption to PTSD. Lippincott-Raven: Philadelphia, 1995.
15. Fanselow MS. Shock-induced analgesia on the formalin test: effects of shock severity, naloxone, hyophysectomy and associative variables. Behav Neurosci 1984; 98: 79-95.
16. Maier SF. Stressor controllability and stress-induced analgesia. Ann NY Acad Sci 1986; 467: 55-72.
17. McGaugh JL, Introini-Collison IB, Cahill LF, Castellano C, Dalmaz C, Parent MB, Williams CL. Neuromodulatory systems and memory storage: role of the amygdala. Behav Brain Res 1993; 38: 81-90.
18. Dalmaz C, Introini-Collison IB, McGaugh JL. Noradrenergic and cholinergic interactions in the amygdala and the modulation of memory storage. Behav Brain Res 1993; 58: 167-174.
19. Norman RJ, Buchwald JS, Villablanca JR. Classical conditioning with auditory discrimination of the eyeblink in decerebrate cats. Science 1977; 196: 551-552.
20. Schmaltz LW, Theios J. Acquisition and extinction of a classically conditioned response in hippocampectomized rabbits. J Comp Physiol Psychol 1972; 79: 328-333.
21. Bliss TVP, Gardner-Medwin AR. Long-lasting potentiation of synaptic transmission in the denate area of the unanesthetized rabbit following stimulation of the perforant path. J Physiology 1973; 232: 357-374.
22. Lynch G, Baudry M. The biochemistry of memory: a new and specific hypothesis. Science 1984; 224: 1057-1063.
23. Sapolsky RM, Uno H, Rebert CS. Hippocampal damage associated with prolonged glucocorticoid exposure in primates. J Neurosci 1990; 10: 2897-2902.
24. Ling M, Perry P, Tsuang M. Side effects of corticosteroid therapy. Arch Gen Psychiatry 1981; 38: 471-477.
25. Wolkowitz OM, Reus VI, Weingartner H. Cognitive effects of corticosteroids. Am J Psychiatry 1990; 147: 1297-1303.
26. Aston-Jones G. Behavioral functions of locus coeruleus derived from cellular attributes. Physiol Psychol 1985; 13: 118-126.
27. Jacobs BL. Locus coeruleus neuronal activity in behaving animals. In: Heal DJ, Marsden CA (eds). The Pharmacology of Noradrenaline in the Central Nervous System. Oxford University Press: Oxford, New York, Tokyo, 1990.
28. Jacobs BL. Brain monoaminergic unit activity in behaving animals. Prog Psychobiol Physiol Psychol 1987; 12: 171-206.
29. Glavin GB. Stress and brain noradrenaline: a review. Behav Neurosci Rev 1985; 9: 233-243.
30. Aston-Jones G, Shipley MT, Chouvet G. Afferent regulation of locus coeruleus neurons: anatomy, physiology, and pharmacology. Prog Brain Res 1991; 88: 47-75.
31. Aston-Jones G, Valentino RJ, VanBockstaele EJ, Meyerson AT. Locus coeruleus, stress, and PTSD: neurobiological and clinical parallels. In: Murburg MM (eds). Catecholamine Function in Posttraumatic Stress Disorder: Emerging Concepts. American Psychiatric Press: Washington, DC, 1994.
32. Simson PE, Weiss JM. Altered activity of the locus coeruleus in an animal model of depression. NeuroPsychopharmacology 1988; 1: 287-295.
33. Wearn JT, Sturgis CC. Studies on epinephrine: effects of the injection of epinephrine in soldiers with 'irritable heart'. Arch Intern Med 1919; 24: 247.
34. Orr SP, Pitman RK, Lasko NB, Herz LR. Psychophysiological assessment of posttraumatic stress disorder imagery in world war II and Korean combat veterans. J Abnorm Psychol 1993; 102: 152-159.
35. Pallmeyer TP, Blanchard EB, Kolb LC. The psychophysiology of combat induced PTSD in Vietnam veterans. Behav Res Ther 1986; 24: 645-652.
36. Blanchard EB, Kolb LC, Gerardi RJ, Ryan P, Pallmeyer TP. Cardiac response to relevant stimuli as an adjunctive tool for diagnostic post-traumatic stress disorder in Vietnam veterans. Behavior Ther 1986; 17: 592-606.
37. Malloy PF, Fairbank JA, Keane TM. Validation of a multi-method assessment of posttraumatic stress disorders in Vietnam veterans. J Cons Clin Psychol 1983; 51: 488-494.
38. McFall ME, Murburg MM, Ko GN, Veith RC. Autonomic responses to stress in Vietnam combat veterans with posttraumatic stress disorder. Biol Psychiatry 1990; 27: 1165-1175.
39. Prins A, Kaloupek DG, Keane TM. Psychophysiological evidence for autonomic arousal and startle in traumatized adult populations. In: Friedman MJ, Charney DS, Deutch AY (eds). Neurobiological and Clinical Consequences of Stress: From Normal Adaption to PTSD. Lippincott-Raven: Philadelphia, 1995.
40. Blanchard EB, Kolb LC, Prins A. Changes in plasma norepinephrine to combat-related stimuli among Vietnam veterans with posttraumatic stress disorder. J Nerv Ment Dis 1991; 179: 371-373.
41. Kosten TR, Mason JW, Giller EL. Sustained urinary norepinephrine and epinephrine elevation in posttraumatic stress disorder. Psychoneuroendocrinology 1987; 12: 13-20.
42. Yehuda R, Southwick S, Giller EL, Ma X, Mason JW. Urinary catecholamine excretion and severity of PTSD symptoms in Vietnam combat veterans. J Nerv Ment Dis 1992; 180: 321-325.
43. De Bellis MD, Lefter L, Trickett PK, Putnam FW. Urinary catecholamine excretion in sexually abused girls. J Am Acad Child Adolesc Psychiat 1994; 33: 320-327.
44. Perry BD, Giller EL, Southwick SM. Altered platelet alpha-adrenergic binding sites in posttraumatic stress disorder. Am J Psychiatry 1987; 144: 1511-1512.
45. Perry BD, Southwick SM, Yehuda R, Giller EL. Adrenergic receptor regulation in posttraumatic stress disorder. In: Giller EL (ed). Biological Assessment and Treatment of Posttraumatic Stress Disorder. American Psychiatric Press: Washington, DC, 1990.
46. Lerer B, Ebstein RP, Shestatsky M. Cyclic AMP signal transduction in posttraumatic stress disorder. Am J Psychiatry 1987; 144: 1324-1327.
47. Lerer B, Bleich A, Bennett ER, Epstein RP, Balkin J. Platelet adenylate cyclase and phospholipase C activity in posttraumatic stress disorder. Biol Psychiatry 1990; 27: 735-744.
48. Gaillard JM. Neurochemical regulation of the states of alertness. Ann Clin Res 1985; 17: 175-184.
49. Davidson LM, Fleming R, Baum A. Chronic stress, catecholamines, and sleep disturbance at Three Mile Island. J Hum Stress 1987; 13: 75-83.
50. Mellman TA, Kumar A, Kulick-Bell R, Kumar M, Nolan B. Nocturnal/daytime urine noradrenergic measures and sleep in combat-related PTSD. Biol Psychiatry 1995; 38: 174-179.
51. McNaughton N, Mason ST. The neuropsychology and neuropharmacology of the dorsal ascending noradrenergic bundle: a review. Prog Neurobiol 1979; 14: 157.
52. Kramer M, Schoen LS, Kinney L. The dream experience in dream disturbed Vietnam veterans. In: Van der Kolk BA (ed). Post Traumatic Stress Disorder: Psychological and Biological Sequelae. American Psychiatric Press: Washington, DC, 1984.
53. Southwick SM, Krystal JH, Morgan CA, Johnson D, Nagy LM, Nicolaou A, Heninger GR, Charney DS. Abnormal noradrenergic function in posttraumatic stress disorder. Arch Gen Psychiatry 1993; 50: 266-274.
54. Charney DS, Woods SW, Price LH, Goodman WK, Glazer WM, Heninger GR. Noradrenergic dysregulation in panic disorder. In: Ballenger JC (ed). Neurobiology of Panic Disorder. Wiley Liss: New York, 1990.
55. Morgan III CA, Grillon C, Southwick SM, Nagy LM, Davis M, Krystal JH, Charney DS. Yohimbine facilitated acoustic startle in combat veterans with post-traumatic stress disorder. Psychopharmacology 1995; 117: 466-471.
56. Bremner JD, Innis RB, Ng CK, Staib LS, Salomon R, Bronen RA, Markey J, Duncan J, Krystal JH, Rich D, Zubal G, Dey H, Soufer R, Charney DS. PET measurement of cerebral metabolic correlates of yohimbine administration in combat-related posttraumatic stress disorder. Am J Psychiatry (in press).
57. Raichle ME, Hartman BK, Eichung JO, Sharpe LG. Central noradrenergic regulation of cerebral blood flow and vascular permeability. Proc Natl Acad Sci 1975; 72: 3726-3730.
58. McCulloch J, Harper AM. Factors influencing the response of the cerebral circulation to phenylethylamine. Neurology 1979; 29: 201-207.
59. Chrousos GP. Regulation and dysregulation of the hypothalamic-pituitary-adrenal axis: the corticotropin-releasing hormone perspective. Endocrin Metab Clin North Am 1992; 21: 833-858.
60. Stark E, Fachet J, Makara GB, Mihaly K. An attempt to explain differences in the hypophyseal-adrenocortical response to repeated stressful stimuli by their dependence of differences in pathways. Acta Med Hung 1968; 25: 251-260.
61. Armario A, Restrepo C, Castellanos JM, Balasch J. Dissociation between adrenocorticotropin and corticosterone response to restrain after previous chronic exposure to stress. Life Sci 1985; 36: 2085-2092.
62. Pitman D, Ottenweller J, Natelson B. Plasma corticosterone levels during repeated presentation of two intensities of restraint stress: chronic stress and habituation. Physiol Behav 1988; 43: 47-56.
63. Pitman D, Ottenweller J, Natelson B, Effect of stressor intensity on habituation and sensitization of glucocort-icoid responses in rats. Behav Neurosci 1990; 104: 28-36.
64. Katz R, Sibel M. Animal model of depression: tests of three structurally and pharmacologically novel antidepressant compounds. Pharmacol Boichem Behav 1982; 16: 973-977.
65. Ottenweller JE, Natelson BH, Pitman DL, Drastal SD. Adrenocortical and behavioral responses to repeated stressors: toward an animal model of chronic stress and stress-related mental illness. Biol Psychiatry 1989; 26: 829-841.
66. Vernikos J, Dallman MF, Bonner C, Katzen A, Shinsako J. Pituitary-adrenal function in rats chronically exposed to cold. Endocrinology 1972; 110: 413.
67. Marti O, Gavalda A, Gomez F, Armario A. Direct evidence for chronic stress-induced facilitation of the adrenocorticotropin response to a novel acute stressor. Neuroendocrinology 1994; 60: 1-7.
68. Mason JW. A re-evaluation of the concept of 'non-specificity' in stress specificity in stress theory. J Psych Res 1971; 8: 323-333.
69. Archibald HC, Tuddenham RD. Persistent stress reaction after combat. Arch Gen Psychiatry 1965; 12: 475-481.
70. Bremner JD, Scott TM, Delaney RC, Southwick SM, Mason JW, Johnson DR, Innis RB, McCarthy G, Charney DS. Deficits in short-term memory in posttraumatic stress disorder. Am J Psychiatiy 1993; 150: 1015-1019.
71. Delaney RC, Rosen AJ, Mattson RH, Novelly RA. Memory function in focal epilepsy, a comparison on non-surgical, unilateral temporal lobe and frontal lobe samples. Cortex 1980; 16: 103-117.
72. Lencz T, McCarthy G, Bronen R, Scott T, Inserni J, Sass K, Novelly R, Kim J, Spencer D. Quantitative magnetic resonance imaging studies in temporal lobe epilepsy: relationship to neuropathology and neuropsychological function. Ann Neurol 1992; 31: 629-637.
73. Bremner JD, Randall P, Scott TM, Bronen RA, Seibyl JP, Southwick SM, Delaney RC, McCarthy G, Charney DS, Innis RB. MRI-based measurement of hippocampal volume in patients with combat-related posttraumatic stress disorder. Am J Psychiatry 1995; 152: 973-981.
74. Yehuda R, Ciller EL, Levengood RA, Southwick SM, Siever LJ. Hypothalamic pituitary adrenal functioning in post-traumatic stress disorder. In: Friedman JM, Charney DS, Deutch AY (eds). Neurobiological and Clinical Consequences of Stress Disorder. Lippincott-Raven: Philadelphia, 1995.
75. Mason JW, Ciller EL, Kosten TR, Ostroff RB, Podd L. Urinary-free cortisol levels in post-traumatic stress disorder patients. J Nerv Ment Dis 1986; 174: 145-159.
76. Yehuda R, Southwick SM, Krystal JH, Bremner D, Charney DS, Mason JW. Enhanced suppression of cortisol following a low dose of dexamethasone in combat veterans with posttraumatic stress disorder. Am J Psychiatry 1993; 150: 83-86.
77. Yehuda R, Southwick SM, Nussbaum G, Ciller EL, Mason JW. Low urinary cortisol excretion in PTSD. J Nerv Ment Dis 1991; 178: 366-369.
78. Lemieux AM, Coe CL. Abuse-related posttraumatic stress disorder: evidence for chronic neuroendocrine activation in women. Psychosom Med 1995; 57: 105-115.
79. Resnick HS, Yehuda R, Pitman RK, Foy DW. Effect of previous trauma on acute plasma cortisol level following rape. Am J Psychiatry 1995; 152: 1675-1677.
80. Yehuda R, Boisoneau D, Lowy MT, Ciller EL. Dose-response changes in plasma cortisol and lymphocyte glucocorticoid receptors following dexamethasone administration in combat veterans with and without posttraumatic stress disorder. Arch Gen Psychiatry 1995; 52: 583-593.
81. Yehuda R, Lowy MT, Southwick SM, Shaffer S, Giller EL. Increased number of glucocorticoid receptor number in post-traumatic stress disorder. Am J Psychiatry 1991; 149: 499-504.
82. Smith MA, Davidson J, Ritchie JC, Kudler H, Lipper S, Chappell P, Nemeroff CB. The corticotropin releasing hormone test in patients with posttraumatic stress disorder. Biol Psychiatry 1989; 26: 349-355.
83. Bremner JD, Licinio J, Darnell A, Krystal JH, Owens MJ, Southwick SM, Nemeroff CB, Charney DS. Elevated concentrations of CSF cortico-releasing factor in posttraumatic stress disorder. Am J Psychiatry (in press).
84. Yehuda R, Resnick H, Kahana B, Giller EL. Persistent hormonal alterations following extreme stress in humans; adaptive or maladaptive? Psychosom Med 1993; 55: 287-297.
85. Valentino RJ, Foote SL, Page ME. The locus coeruleus as a site for integrating corticotropin-releasing factor and noradrenergic mediation of stress responses. In: Tache Y, Rivier C (eds). Corticotropin-releasing Factor and Cytokines: Role in the Stress Response, vol 697. The New York Academy of Sciences: New York, 1993.
86. Chappell PB, Smith MA, Kitts CD, Bissette G, Ritchie J, Anderson C, Nemeroff CB. Alterations in corticotropin-releasing factor-like immunoreactivity in discrete rat brain regions after acute and chronic stress. J Neuroscience 1986; 6: 2908-2914.
87. Swanson LW, Sawchenko PE. Hypothalamic integration: organization of the paraventricular and supraoptic nuclei. Ann Rev Neuro 1983; 6: 269-324.
88. Heilig M, Koob GF, Ekman R, Britton KT. Corticotropin-releasing factor and neuropeptide Y: role in emotional integration. TINS 1994; 17: 80-85.
89. Liang KC, Melia KR, Miserendino MJD, Falls WA, Campeau S, Davis M. Corticotropin-releasing factor: long-lasting facilitation of the acoustic startle reflex. J Neurosci 1992; 12: 2303-2312.
90. Swerdlow NR, Geyer MA, Vale WW, Koob GF. Cortico-releasing factor potentiates acoustic startle response in rats: blockade by chlordiazepoide. Psychopharmacology 1986; 88: 147-152.
91. Swerdlow NR, Britton KT, Koob GF. Potentiation of acoustic startle by cortico-releasing factor (CRF) and by fear are both reversed by alpha-helical CRF(9-41). Neuropsychopharmacology 1989; 2: 285-292.
92. Baldwin HA, Rassnick S, Rivier J, Koob GF, Britton KT. CRF antagonist reverses the 'anxiogenic' response to ethanol withdrawal in the rat. Psychopharmacology 1991; 103: 227-232.
93. Berridge CW, Dunn AJ. A corticotropin-releasing factor antagonist reverses the stress-induced changes of exploratory behavior in mice. Horm Behav 1987; 21: 393-401.
94. Takahashi LK, Kalin NH, Baker EW. Corticotropin-releasing factor antagonist attenuates defensive-withdrawal behavior elicited by odors of stressed conspecifics. Behav Neurosci 1990; 104: 386-389.
95. Valentino R, Foote S. Corticotropin-releasing hormone increases tonic but not sensiory-evoked activity of noradrenergic locus coeruleus neurons in unanesthetized rats. J Neurosci 1988; 8: 1016-1025.
96. Chappell P, Smith M, Kilts C, Bissette G, Ritchie J, Anderson C, Nemeroff C. Alterations in corticotropin-releasing factor-like immunoreactivity in discrete rat brain regions after acute and chronic stress. J Neurosci 1986; 6: 2908-2914.
97. Weiss J, Stout J, Aaron M, Owens M, Nemeroff C. Experimental studies of depression and anxiety: role of locus coeruleus and corticotropin-releasing factor. Brain Res Bull 1994; 35: 561-572.
98. Butler P, Weiss J, Stout J, Nemeroff C. Corticotropin-releasing factor produces fear-enhancing and behavioral activating effects following infusion into the locus coeruleus. J Neurosci 1990; 10: 176-183.
99. Liang K, Lee E. Intra-amygdala injections of corticotropin releasing factor facilitate inhibitory avoidance learning and reduce exploratory behavior in rats. Psychopharmacology 1988; 96: 232-236.
100. Ray A, Henke PG, Gulati K, Sen P. The amygdaloid com-plex, corticotropin releasing factor and stress-induced gastric ulcerogenesis in rats. Brain Res 1993; 624: 286-290.
101. Pich EM, Lorang M, Yeganeh M, Rodriguez de Fonseca F, Raber J, Koob GF, Weiss F. Increase of extracellular corticotropin-releasing factor-like immunoreactivity levels in the amygdala of awake rats during restraint stress and ethanol withdrawal as measured by microdialysis. J Neurosci 1995; 15: 5439-5447.
102. Feldman S, Conforti N, Saphier D. The preoptic area and bed nucleus of the stria terminalis are involved in the effects of the amygdala on adrenocortical secretion. Neuroscience 1990; 37: 775-779.
103. Henke PG, The bed nucleus of the stria terminalis and immobilization stress: unit activity, escape behavior, and gastric pathology in rats. Behav Brain Res 1984; 11: 35-45.
104. Casada JH, Dafny N. Evidence for two different afferent pathways carrying stress-related information (noxious and amygdala stimulation) to the bed nucleus of the stria terminalis. Brain Res 1992; 579: 93-98.
105. Shaikh MB, Brutus M, Siegel HE, Siegel A. Regulation of feline aggression by the bed nucleus of the stria terminalis. Brain Res Bull 1986; 16: 179-182.
106. Saphier D, Feldman S. Electrophysiology of limbic fore-brain and paraventricular nucleus connections. Brain Res Bull 1986; 17: 743-750.
107. Sawchenko PE, Swanson LW. The organization of fore-brain afferents to the paraventricular and supraoptic nuclei of the rat. J Comp Neurol 1983; 218: 121-144.
108. Price JL, Russchen FT, Amaral DG. The limbic region. II. The amygdaloid complex. In: Bjorkland A, Hokfelt T, Swanson LW (eds). Handbook of Chemical Neuroanatomy, vol 5. Elsevier: Amsterdam, 1987.
109. Holstege G, Meiners L, Tan K. Projections of the bed nucleus of the stria terminalis to the mesencephalon, pons, and medulla oblongata in the cat. Exp Brain Res 1985; 58: 370-391.
110. Weller KL, Smith DA. Afferent connections to the bed nucleus of the stria terminalis. Brain Res 1982; 232: 255-270.
111. Cullinan WE, Herman JP, Watson SJ. Ventral subicular interaction with the hypothalamic paraventricular nucleus: evidence for a relay in the bed nucleus of the stria terminalis. J Comp Neurol 1993; 332: 1-20.
112. Lee Y, Davis M. The role of the bed nucleus of the stria terminalis in CHR-enhanced startle: an animal model of anxiety. Soc Neurosci Abs (in press).
113. Thierry AM, Tassin JP, Blanc G, Glowinski J. Selective activation of the mesocortical dopamine system by stress. Nature 1976; 263: 242-244.
114. Young WS, Kuhar MJ. Radiohistochemical localization of benzodiazepine receptors in rat brain. J Pharmacol Exp Ther 1980; 212: 337-346.
115. Dunn AJ. Stress-related activation of cerebral dopaminergic system. Ann NY Acad Sci 1988; 537: 188-205.
116. Abercrombie ED, Keefe KA, DiFrishia DS, Zigmund MJ. Differential effect of stress on in vivo dopamine release in striatum, nucleus accumbens, and medial frontal cortex. J Neurochem 1989; 52: 1655-1658.
117. Mantz J, Thierry AM, Glowinski J. Effect of noxious tail pinch on the discharge rate of mesocortical and mesolimbic dopamine neurons: selective activation of the mesocortical system. Brain Res 1989; 476: 377-381.
118. Deutch AY, Tam SY, Roth RH. Footshock and conditioned stress increase 3,4-dihydroxyphenylacetic, acid (DOPAC) in the ventral tegmental area but not substantia nigra. Brain Res 1985; 333: 143-146.
119. Davis M, Hitchcock JM, Bowers MB, Berridge CW, Melia KR, Roth RH. Stress-induced activation of prefontal cortex dopamine turnover: blockade by lesions of the amygdala. Brain Res 1994; 664: 207-210.
120. Kinzie JD, Boehnlein JJ. Post-traumatic psychosis among Cambodian refugees. J Traum Stress 1989; 2: 185-198.
121. Bertolucci-D'Angio M, Serrano A, Driscoll P, Scatton B. Involvement of mesocorticolimbic dopaminergic systems in emotional states. Cortex 1990; 85: 405-417.
122. D'Angio M, Serrano A, Driscoll P, Scatton B. Stressful environmental stimuli increase extracellular DOPAC levels in the prefrontal cortex of hypoemotional (Roman high-avoidance) but not hyperemotional (Roman low-avoidance) rats. An in vivo voltammetric study. Brain Res 1988; 451: 1237-1247.
123. Roy-Byrne P, Uhde TW, Sack DA. Plasma HVA and anxiety in patients with panic disorder. Biol Psychiatry 1986; 21: 847-849.
124. Sorg BA, Kalivas PW. Stress and neuronal sensitization. In: Friedman MJ, Charney DS, Deutch AY (eds). Neurobiological and Clinical Consequences of Stress: From Normal Adaptation to PTSD. Lippincott-Raven Publishers: Philadelphia, 1995.
125. Hamner MB, Diamond BI. Elevated plasma dopamine in postraumatic stress disorder: a preliminary report. Biol Psychiatry 1993; 33: 304-306.
126. Davis M. The mammalian startle response. In: Eaton RC (ed). Neural Mechanisms of Startle Behavior. Plenum Press: New York, 1984.
127. Mueser KT, Butler RW. Auditory hallucinations in combat-related chronic posttraumatic stress disorder. Am J Psychiatry 1987; 144: 299-302.
128. Babbini M, Davis WM. Time-dose relationship for locomotor activity effects of morphine after acute or repeated treatment. Br J Pharmacol 1972; 46: 213-224.
129. Herman BH, Goldstein A. Antinociception and paralysis induced by intrathecal dynorphine A. J Pharmacol Exp Ther 1985; 232: 27-32.
130. Roques PB, Fournie-Zaluski M, Soroca E, Lecomte MJ, Malfroy B, Llorens C, Schwartz J-C. The enkephalinse inhibitor thiorphan shows antinociceptive activity in mice. Nature 1980; 288: 286-288.
131. Urea G, Yitzhaky J, Frenk H. Different opioid systems may participate in post-electroconvulsive shock (ECS) analgesia and catalepsy. Brain Res 1981; 219: 385-396.
132. Williams JL, Worland PD, Smith MG. Defeat-induced hypoalgesia in the rat: effects of conditioned odors, naltrexone and extinction. J Exp Psychol Animal Behav Proc 1990; 16: 345-357.
133. Fanselow MS. Conditioned fear-induced opiate analgesia: a competing motivational state theory of stress induced analgesia. In: Kellv D (ed). Ann NY Acad Sci. vol 467. New York Academy of Sciences: New York, 1986.
134. Helmstetter FJ, Bellgowan PS. Lesions of the amygdala block conditional hypoalgesia on the tail flick test. Brain Res 1993; 612: 253-257.
135. 134b Millan MJ. Multiple opioids system and pain. Pain 1986; 27: 303-348.
136. Watkins LR, Wiertelak EP, Maier SF. Kappa opiate receptors mediate tail-shock induced antinociception at supra-spinal levels. Brain Res 1992; 582: 1-9.
137. Watkins LR, Wiertelak EP, Maier SF. Delta opiate receptors mediate tail-shock induced antinociception at supra-spinal levels. Brain Res 1992; 582: 10-21.
138. Takahashi M, Senda T, Tokuyama S, Kaneto H. Further evidence for the implication of k opioid receptor mechanism in the production of psychological-induced analgesia. Japan J Pharmacol 1990; 53: 487-494.
139. Wiertelak EP, Yang H-YT, Mooney-Heiberger K, Maier SF, Watkins LR. The nature of conditioned anti-analgesia: spinal cord opiate and anti-opiate nourochemistry. Brain Res 1994; 634: 214-226.
140. Nabeshima T, Matsuno K, Kameyama T. Involvement of different opioid receptor subtypes in electric shock-induced analgesia and motor suppression in the rat. Eur J Pharmacol 1985; 114: 197-207.
141. Nabeshima T, Yamada K, Kameyama T. Contribution of different opioid systems to footshock-induced analgesia and motor suppression. Eur J Pharmacol 1983; 92: 199-205.
142. Pitman RK, van der Kolk BA, Orr SP, Greenberg MS. Naloxone-reversible analgesic response to combat-related stimuli in posttraumatic stress disorder. Arch Gen Psychiatry 1990; 47: 541-544.
143. Friedman MJ. Biological approaches to the diagnosis and treatment of post-traumatic: stress disorder. J Traumatic Stress 1991; 4: 67-91.
144. Hoffman L, Watson PD, Wilson G, Montgomery J. Low plasma beta-endorphin in post-traumatic stress disorder. Austr New Zeal J Psychiatr 1989; 29: 268-273.
145. Wolfe I, Mosnaim AD, Puente J, Ignacio R. Plasma methionine enkephalin in PTSD. Biol Psychiatry 1991; 29: 305-307.
146. van der Kolk BA, Greenberg MS, Orr SP, Pitman RK. Endogenous opioids, stress induced analgesia, and post-traumatic stress disorder. Psychopharmacol Bull 1989; 25: 417-421.
147. Panksepp J, Siviy SM, Normansell LA. Brain opioids and social emotions. In: Reite M, Field T (eds). The Psychobiology of Attachment and Separation. Academic Press: New York, 1985.
148. File SE. Naloxone reduces social and exploratory activity in the rat. Psychopharmacology 1980; 7: 41-44.
149. Panksepp J, Herman BH, Bishop P, DeEskinazi FG. Endogenous opioids and social behavior. Neurosci Biobehav Rev 1980; 4: 473-487.
150. Alexander BK, Coambs RB, Hadaway PF. The effects of housing and gender on morphine self-administration in rats. Psychopharmacology 1978; 58: 175-179.
151. Yitzhaky F, Frenk H, Urca G. Kindling-induced changes in morphine analgesia and catalepsy: evidence for independent opioid systems. Brain Res 1982; 237: 193-201.
152. Yamada K, Nebeshima T. Stress-induced behavioral responses and multiple opioid systems in the brain. Behav Brain Res 1995; 67: 133-145.
153. Kolb LC. A neuropsychological hypothesis explaining posttraumatic stress disorders. Am J Psychiatry 1987; 144: 989-995.
154. Solomon R, Kamin LJ. Wynne LC. Traumatic avoidance learning: the outcomes of several extinction programs in dogs. J Abnorm Social Psychol 1953: 48: 291.
155. Keane TM, Zimmering RT, Gaddell JM. A behavioral formulation of post traumatic stress disorder in Vietnam veterans. Behav Therap 1985; 8: 9-12.
156. Krystal JH, Kosten TR, Southwick S, Mason JW. Neurobiological aspects of PTSD: review of clinical and preclinical studies. Behav Therap 1989; 20: 177-198.
157. Weiss JM, Stone EA, Harrell N. Coping behavior and brain norepinephrine levels in rats. J Comp Physiol Psychiatry 1970; 22: 153.
158. Anisman HL, Sklar LS. Catecholamine depletion in mice upon re-exposure to stress: mediation of the escape deficits provided by inescapable shock. J Comp Physiol Psychol 1979; 93: 610.
159. Charney DS, Deutch AY, Krystal JH, Southwick SM, Davis M. Psychobiologic mechanisms of posttraumatic stress disorder. Arch Gen Psychiatry 1993; 50: 294-305.
160. Yehuda R, Antelman SM. Criteria for rationally evaluating animal models of posttraumatic stress disorder. Biol Psychiatry 1993; 33: 479-486.
161. Post RM, Weiss SRB, Smith MA. Sensitization and kindling: implications for the evolving neural substrates of post-traumatic stress disorder. In: Friedman MJ, Charney DS, Deutch AT (eds). Neurobiological and Clinical Consequences of Stress: From Normal Adaption to PTSD. Lippincott-Raven: Philadelphia, 1995.
162. Foa EB, Zinbarg R, Rothbaum BO. Uncontrollability and unpredictability in post-traumatic stress disorder: an animal model. Psychol Bull 1992: 112: 218-238.
163. Blanchard DC, Blanchard RJ. Innate and conditioned reactions to threat in rats with amygdaloid lesions. J Comp Physiol Psychol 1972; 81: 281-290.
164. Bolles RC, Fanselow MS. A perceptual-defense-recuperative model of fear and pain. Behav Brain Sci 1980; 3: 291-323.
165. Rescorla R. Effect of inflation of the unconditioned stimulus value following conditioning. J Comp Physio Psychol 1974; 86: 101-106.
166. White K, Davey GCL. Sensory preconditioning and UCS inflation in human 'fear' conditioning. Behav Res Ther 1989; 27: 161-166.
167. Davey GCL, DeJong PJ, Tallis F. UCS inflation in the aetiology of a variety of anxiety disorders: some case histories. Behav Res Ther 1993; 31: 495-498.
168. Ohman A, Soares JJF. On the automatic nature of phobic fear: conditioned electrodermal responses to masked fear-relevant stimuli. J Abn Psychol 1993; 102: 121-132.
169. Romanski LM, LeDoux JE. Bilateral destruction of neocortical and perirhinal projection targets of the acoustic thalamus does not disrupt auditory fear conditioning. Neurosci Lett 1992; 142: 228-232.
170. Romanski LM, LeDoux JE. Equipotentiality of thalamo-amygdala and thalamo-cortico-amygdala circuits in auditory fear conditioning. J Neurosci 1992: 12: 4501-4509.
171. LeDoux JE. Emotional memory systems in the brain. Behav Brain Res 1993; 58: 69-79.
172. Selye H. Confusion and controversy in the stress field. J Hum Stress 1975; 1: 37-44.
173. Amaral D. Memory: anatomical organization of candidate brain regions. In: Plum F (ed). Handbook of Physiology. Sect 1: Neurophysiology, vol 5: Higher Functions of the Brain. American Physiological Society: Bethesda, MD, 1987.
174. LeDoux JE, Cicchetti P, Xagoraris A, Romanski LM. The lateral amygdaloid nucleus: sensory interface of the amygdala in fear conditioning. J Neurosci 1990; 10: 1062-1069.
175. Ottersen OP, Ben-Ari Y. Afferent connections to the amygdaloid complex of the rat and cat: projections from the thalamus. J Comp Neurol 1979; 187: 401-424.
176. Aggleton JP. The Amygdala: Neurobiological Aspects of Emotion, Memory, and Mental Dysfunction. Wiley-Liss: New York, 1992.
177. Halgren E. Emotional neurophysiology of the amygdala within the context of human cognition. In: Aggleton JP (eds). The Amygdala. Wiley-Liss: New York, 1992.
178. Mahl GF, Rothenberg A, Delgado GMR, Hamlin H. Psychological responses in the human to intracerebral electrical stimulation. Psychosom Med 1964; 26: 337-368.
179. Horowitz MJ, Adams JE. Hallucinations on brain stimulation: evidence for revision of the Penfield hypothesis. In: Keup W (ed). Origin and Mechanism of Hallucinations. Plenum Press: New York, 1970.
180. Rayport M, Ferguson SM. Qualitative modification of sensory responses to amygdaloid stimulation in man by interview content and context. Elect Clin Neuro 1974; 34: 714.
181. Grossman SP, Gossman L, Walsh L. Functional organization of the rat amygdala with respect to avoidance behavior. J Comp Physiol Psychol 1975; 88: 829-850.
182. Cahill L, McGaugh JL. Amygdaloid complex lesions differentially affect retention of tasks using appetitive and aversive reinforcement. Behav Neurosci 1990; 104: 532-543.
183. Dunn LT, Everitt BJ. Double dissociations of the effects of amygdala and insular cortex lesions on conditioned taste aversion, passive avoidance, and neophobia in the rat using excitotoxin ibotenic acid. Behav Neurosci 1988; 102: 3-23.
184. David M. The role of the amygdala in conditioned fear. In: Aggleton J (ed). The Amygdala: Neurobiological Aspects of Emotion, Memory, and Mental Dysfunction. Wiley-Liss: New York, 1992.
185. Pascoe JP, Kapp BS. Electrophysiological characteristics of amygdaloid central nucleus neurons during Pavlovian fear conditioning in the rabbit. Behav Brain Res 1985; 16: 117-133.
186. Brioni JD, Nagahara AH, McGaugh JL. Involvement of the amygdala GABAergic system in the modulation of memory storage. Brain Res 1989; 487: 105-112.
187. Gallagher M, Kapp BS. Manipulation of opiate activity in the amygdala alters memory processes. Life Sci 1978; 23: 1973-1978.
188. Pezzone MA, Lee WS, Hoffman GE, Pezzone KM. Rabin BS. Activation of brainstem catecholaminergic neurons by conditioned and unconditioned aversive stimuli as revealed by c-fos immunoreactivity. Brain Res 1993; 608: 310-318.
189. Pezzone MA, Lee WS, Hoffman GE, Rabin BS. Induction of c-fos immunoreactivity in the rat forebrain by conditioned and unconditioned aversive stimuli. Brain Res 1992; 597: 41-50.
190. Smith MA, Banerjee S, Gold PW, Glowa J. Induction of c-fos mRNA in rat brain by conditioned and unconditioned Stressors. Brain Res 1992; 578: 135-141.
191. Campeau S, Hayward MD, Hope BT, Rosen JB, Nestler EJ, Davis M. Induction of the c-fos proto-oncogene in rat amygdala during unconditioned and conditioned fear. Brain Res 1991; 565: 349-352.
192. Miserendino MJD, Sananes CB, Melia KR, Davis M. Blocking of acquistion but not expression of conditioned fear-potentiated startle by NMDA antagonists in the amygdala. Nature 1990; 345: 716-718.
193. Campeau S, Miserendino MJD, Davis M. Intra-amygdala infusion of the N-methyl-D-aspartate receptor antagonist AP5 blocks acquistion but not expression of fear-potentiated startle to an auditory conditioned stimulus. Behav Neurosci 1992; 106: 569-574.
194. Kim M, McGaugh JL. Effects of intra-amygdala injections of NMDA receptor antagonists on acquisition and retention of inhibitory avoidance. Brain Res 1992; 585: 35-48.
195. Fanselow MS, Kim JJ, Landeria-Fernandez J. Anatomically selective blockade of pavlovian fear conditioning by application of an NMDA antagonist to the amygdala and periaqueductal gray. Soc Neurosci Abs 1991; 17: 659.
196. Liang KC, Davis M. Intra-amygdala injection of N-methyl-D-aspartate receptor antagonists impairs memory in an inhibitory avoidance task. Soc Neuro Abs 1990: 16: 767.
197. Melia KR, Falls WA, Davis M. Involvement of pertussis toxin sensitive G-proteins in conditioned fear-potentiated startle: possible involvement of the amygdala. Brain Res 1992; 584: 141-148.
198. Zajonc R. Feeling and thinking: preferences need no inferences. Am Psychol 1980; 35: 151-175.
199. LeDoux JE, Romanski L, Xagoraris A. Indelibility of subcortical emotional memories. J Cog Neurosci 1989; 1: 238-243.
200. Shalev AY, Rogel FY, Pitman RK. Conditioned fear and psychological trauma. Biol Psychiatry 1992; 31: 863-865.
201. Konorski J. Conditioned Reflexes and Neuronal Organization. Cambridge UP: London, 1948.
202. Rescorla RA. Conditioned inhibition and excitation. In: Dickinson A, Boakes RA (eds). Mechanisms of Learning and Motivation: A Memorial Volume to Jerzy Konorski. Erlbaum: Hillside, NJ, 1979.
203. Bouton ME, Swartzentruber D. Sources of relapse after extinction in Pavlovian and instrumental learning. Clin Psychol Rev 1991; 11: 123-140.
204. Falls WA, Miserendino MJD, Davis M. Extinction of fear-potentiated startle: blockade by infusion of an NMDA antagonist into the amygdala. J Neurosci 1992; 12: 854-863.
205. Rainnie DG, Asprodini EK, Shinnick-Gallagher P. Inhibitory transmission in the basolateral amygdala. J Neurophysiol 1991; 66: 99-109.
206. Teich AH, McCabe PM, Gentile CC, Schneiderman LS, Winters RW, Liskowsky DR, Schneiderman N. Auditory cortex lesions prevent the extinction of Pavlovian differential heart rate conditioning to tonal stimuli in rabbits. Brain Res 1989; 480: 210-218.
207. Morgan MA, Romanski LM, LeDoux JE. Extinction of emotional learning: contribution of medial prefrontal cortex. Neurosci Lett 1993; 163: 109-113.
208. Rescorla R, Heth C. Reinstatement of fear to an extinguished conditioned stimulus. J Exp Psychol: Animal Behav Proc 1975; 104: 88-96.
209. Solomon Z, Garb R, Bleich A, Grupper D. Reactivation of combat-related posttraumatic stress disorder. Am J Psychiatry 1987; 144: 51-55.
210. Mineka S, Tomarken AJ. The role of cognitive biases in the origins and maintenance of fear and anxiety disorders. In: Archer T, Nilsson LE (eds). Aversion, Avoidance, and Anxiety. Lawrence Erlbaum: Hillsdale, NJ, 1989.
211. Kim JJ, Fanselow MS. Modality-specific retrograde amnesia of fear. Science 1992; 256: 675-677.
212. Phillips RG, LeDoux JE. Differential contribution of amygdala and hippocampus to cued and contextual fear conditioning. Behav Neurosci 1992; 106: 274-285.
213. Kim JJ, Decola JP, Landeira-Fernandez J, Fanselow MS. N-methyl-D-aspartate receptor antagonist APV blocks acquisition but not expression of fear conditioning. Behav Neurosci 1991; 105: 126-133.
214. Maren S, DeCola JP, Swain RA, Fanselow MS, Thompson RF. Parallel augmentation of hippocampal long-term potentiation, theta rhythm, and contexual fear conditioning in water-deprived rats. Behav Neuro 1994; 108: 44-56.
215. Selden NRW, Everitt BJ, Jarrard LE, Robbins TW. Complementary roles for the amygdala and hippocampus in aversive conditioning to explicit and contextual cues. Neuroscience 1991; 42: 335-350.
216. McAlonan M, Wilkinson LS, Robbins TW, Everitt BJ. The effects of AMPA-induced lesions of the septo-hippocampal cholinergic projection on aversive conditioning to explicit and contextual cues and spatial learning in the water maze. Eur J Neurosci 1995; 7: 281-292.
217. Wilkinson LS, Humby T, Robbins TW, Everitt BJ. Differential effects of forebrain 5-hydroxytryptamine depletions on Pavlovian aversive conditioning to discrete and contextual stimuli in the rat. Eur J Neurosci 1995; 7: 2042-2052.
218. Davis M, Gewirtz JC, McNish KA, Kim M. The roles of the amygdala and bed nucleus of the stria terminalis (BNST) in the acquisition of fear potentiated startle using both explicit and contextual cues. In: Society for Neuroscience Abstracts, vol 21. Society for Neuroscience, 1995.
219. Introini-Collison IB, Arai Y, McGaugh JL. Stria terminalis lesions attenuate the effects of posttraining oxotremorine and atropine on retention. Psychobiology 1989; 17: 397-401.
220. Liang KC, McGuagh JL. Lesions of the stria terminalis attenuate the amnestic effect of amygdaloid stimulation on avoidance responses. Brain Res 1983; 274: 309-318.
221. Liang KC, McGaugh JL. Lesions of the stria terminalis attenuate the enhancing effect of posttraining epinephrine on retention of an inhibitory avoidance response. Behav Brain Res 1983; 9: 49-58.
222. McGaugh JL, Instroini-Collison IB, Juler RG, Izquierdo I. Stria terminalis lesions attenuate the effects of posttraining naloxone and beta-endorphin on retention. Behav Neurosci 1986; 100: 839-844.
223. McGaugh JL, Introini-Collison IB, Cahill L, Kim M, Liang KC. Involvement of the amygdala in neuromodulatory influences on memory storage. In: Aggleton JP (ed). The Amygdala: Neurobiological Aspects of Emotion, Memory, and Mental Dysfunction. Wiley-Liss: New York, 1992.
224. Davis M. Diazepam and flurazepam: effects on conditioned fear as measured with the potentiated startle paradigm. Psychopharmacology 1979; 62: 1-7.
225. Ross RJ, Ball WA, Cohen ME, Silver SM, Morrison AR, Dinges DF. Habituation of the startle reflex in posttraumatic stress disorder. J Neuropsych 1989; 1: 305-307.
226. Shalev AY, Orr SP, Peri T, Schreiber S, Pitman RK. Physiologic response to loud tones in Israeli patients with postraumatic stress disorder. Arch Gen Psychiatry 1992; 49: 870-875.
227. Ornitz EM, Pynoos RS. Startle modulation in children with posttraumatic stress disorder. Am J Psychiatry 1989; 146: 866-870.
228. Butler RW, Braff DL, Rausch JL, Jenkins MA, Sprock J, Geyer MA. Physiological evidence of exaggerated startle response in a subgroup of Vietnam veterans with combat-related PTSD. Am J Psychiatry 1990; 147: 1308-1312.
229. Orr SP, Lasko NB, Shalev AY, Pitman RK. Physiological responses to loud tones in Vietnam Veterans with posttraumatic stress disorder. J Abn Psychol 1995; 104: 75-82.
230. Grillon C, Morgan CA, Southwick SM, Davis M, Charney DS. Baseline startle amplitude and prepulse inhibition in Vietnam veterans with PTSD. Psychiatry Res (in press).
231. Morgan III CA, Grillon C, Southwick SM, Davis M, Charney DS. Fear-potentiated startle in posttraumatic stress disorder. Biol Psychiatry 1995; 38: 378-385.
232. Grillon C, Pellowski M, Merikangas K. The startle reflex is facilitated by darkness in humans. Biol Psychiatry 1996; 39: 555.
233. Grillon C, Morgan CA, Davis M, Southwick SM. Effects of experimental context and explicit threat cues on acoustic startle in Vietnam veterans with posttraumatic stress disorder, (submitted).
234. Brownstein M, Saavedra MM, Palkovits M. Norepinephrine and domaine in the limbic system of the rat. Brain Res 1974; 79; 431-436.
235. Gold PE, van Buskirk RB. Effects of alpha- and beta-adrenergic receptor antagonists on posttrial epinephrine modulation of memory: relationship to posttraining brain norepinephrine concentrations. Behav Biol 1978; 24: 1168-1184.
236. Introini-Collison IB, McGaugh JL. Epinephrine modulates long-term retention of an aversively motivated discrimination task. Behav Neural Biol 1986; 45: 358-365.
237. Introini-Collison IB, McGaugh JL. Naloxone and B-endorphin after the effects of posttraining epinephrine on memory. Psychopharmacology 1987; 92: 229-235.
238. McCarty R, Gold PE. Plasma catecholamines: effects of footshock level and hormonal modulators of memory storage. Horm Behav 1981; 15: 168-182.
239. Gold PE, van Buskirk R. Facilitation of time-dependent memory processes with posttrial epinephrine injections. Behav Biol 1975; 13: 145-153.
240. Cahill L, Prins B, Weber M, McGaugh JL. β-Adrenergic activation and memory for emotional events. Nature 1994; 371: 702-704.
241. Pitman RK. Post-traumatic stress disorder, hormones, and memory. Biol Psychiatry 1989; 26: 221-223.
242. McGaugh JL. Hormonal influences on memory. Ann Rev Psychol 1983; 34: 297-323.
243. Goddard GV, McIntyre DC, Leech CK. A permanent change in brain function resulting from daily electrical stimulation. Exp Neurol 1969; 25: 295-330.
244. Post RM, Weiss SRB, Pert A. Implications of behavioral sensitization and kindling for stress induced behavioral change. In: Chrousos GP, Loriaux DL, Gold PH (eds). Mechanisms of Physical and Emotional Stress. Plenum Press: New York, 1988.
245. Solomon Z, Oppenheimer B, Noy S. Subsequent military adjustment of combat stress reaction casualties - a nine year follow-up study. Military Med 1986; 151: 8-11.
246. Friedman MJ. Neurobiological sensitization models of post-traumatic stress disorder: their possible relevance to multiple chemical sensitivity syndrome. Toxicol Ind Health 1994; 10: 449-462.
247. Davidson J. Issues in the diagnosis of post-traumatic stress disorder. In: Oldman JM, Riba MB, Tasman A (eds). Review of Psychiatry, Vol 12. American Psychiatric Press: Washington DC.
248. Bremner JD, Southwick SM, Johnson DR, Yehuda R, Charney DS. Childhood abuse in combat-related post-traumatic stress disorder. Am J Psychiatry 1993: 150: 235-239.
249. McFarlane AC. The longitudinal cause of post-traumatic morbidity: the range of outcomes and their predictors. J Nerv Ment Dis 1988; 176: 30-39.
250. Davis M. Sensitization of the acoustic startle reflex by footshock. Behav Neurosci 1989; 103: 495-503.
251. Servatius RJ, Ottenweller JE, Natelson BH. Delayed startle sensitization distinguishes rats exposed to one or three stress sessions: further evidence toward an animal model of PTSD. Biol Psychiatry 1995; 38: 539-546.
252. Morgan CA III, Grillon C, Southwick SM, Charney DS. Exaggerated acoustic startle reflex in Gulf war veterans with posttraumatic stress disorder. Am J Psychiatry 1996; 153: 64-68.
253. Putnam F. Dissociative disorders in children: behavioral profiles and problems. Child Abuse and Neglect 1993; 17: 39-45.
254. Kalivas PW, Stewart J. Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activity. Brain Res Rev 1991; 16: 223-224.
255. Perugini M, Vezina P. Amphetamine administered to the ventral tegmental area sensitizes rats to the locomotor effects of nucleus accumbens amphetamine. J Pharmacol Exp Ther 1994; 270: 690-696.
256. Kalivas PW, Alesdatter JE. Involvement of N-methyl-D-aspartate in the ventral tegmental area and amygdala in behavioral sensitization to cocaine. J Pharmacol Exp Ther 1993; 267: 486-495.
257. Kalivas PW, Duffy P. Effect of acute and daily cocaine treatment on extracellular dopamine in the nucleus accumbens. Synapse 1990; 5: 48-58.
258. Castaneda E, Becker JB, Robinson TE. The long-term effects of repeated amphetamine treatment in vivo on amphetamine, KC1 and electrical stimulation evoked striatal dopamine release in vitro. Life Sci 1988; 42: 2447-2456.
259. Kolta MG, Shreve P, De Souza V, Uretsky NJ. Time course of the development of the enhanced behavioral and biochemical responses to amphetamine after pre-treatment with amphetamine. Neuropharmacology 1985; 24: 823-829.